Cline Christopher R.'s Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed May 6, 2026
- Accession no.
- 0001943192-26-000004
- Filed
- May 6, 2026
- Trade date
- May 4-6, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $115.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cline Christopher R.CIK 0001943192 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | MOption exerciseAcquired | +4,250 | $0.00 | $0 | 121,149 | Direct | |
| May 5, 2026 | Common Stock | SSaleDisposed | −2,181 | $46.65 | −$101,743.65 | 118,968 | Direct | |
| May 6, 2026 | Common Stock | SSaleDisposed | −310 | $43.95 | −$13,624.5 | 118,658 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | AGrant or awardAcquired | +8,500 | $0.00 | $0 | 8,500 | Direct | |
| May 4, 2026 | Common Stock | MOption exerciseDisposed | −4,250 | $0.00 | $0 | 4,250 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.